530 related articles for article (PubMed ID: 30987058)
1. Nutraceuticals for the Treatment of Diabetic Retinopathy.
Rossino MG; Casini G
Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987058
[TBL] [Abstract][Full Text] [Related]
2. Diabetic Retinopathy: Pathophysiology and Treatments.
Wang W; Lo ACY
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925789
[TBL] [Abstract][Full Text] [Related]
3. SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis.
Mudaliar S; Hupfeld C; Chao DL
J Clin Endocrinol Metab; 2021 Apr; 106(5):1235-1244. PubMed ID: 33512450
[TBL] [Abstract][Full Text] [Related]
4. Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.
Ibrahim AS; Tawfik AM; Hussein KA; Elshafey S; Markand S; Rizk N; Duh EJ; Smith SB; Al-Shabrawey M
Biochim Biophys Acta; 2015 Mar; 1851(3):290-8. PubMed ID: 25562624
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
6. Role of leukotrienes in diabetic retinopathy.
Behl T; Kaur I; Kotwani A
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():1-9. PubMed ID: 26673555
[TBL] [Abstract][Full Text] [Related]
7. Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems.
Ye X; Fung NSK; Lam WC; Lo ACY
Nutrients; 2024 May; 16(11):. PubMed ID: 38892648
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
Jiang S; Chen X
Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
[TBL] [Abstract][Full Text] [Related]
9. Modulation of microglia in the retina: new insights into diabetic retinopathy.
Arroba AI; Valverde ÁM
Acta Diabetol; 2017 Jun; 54(6):527-533. PubMed ID: 28349217
[TBL] [Abstract][Full Text] [Related]
10. A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy.
Deliyanti D; Lee JY; Petratos S; Meyer CJ; Ward KW; Wilkinson-Berka JL; de Haan JB
Clin Sci (Lond); 2016 Aug; 130(15):1375-87. PubMed ID: 27005782
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection as a Therapeutic Target for Diabetic Retinopathy.
Hernández C; Dal Monte M; Simó R; Casini G
J Diabetes Res; 2016; 2016():9508541. PubMed ID: 27123463
[TBL] [Abstract][Full Text] [Related]
12. Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment.
Ou K; Copland DA; Theodoropoulou S; Mertsch S; Li Y; Liu J; Schrader S; Liu L; Dick AD
J Cell Mol Med; 2020 Apr; 24(7):3958-3970. PubMed ID: 32141716
[TBL] [Abstract][Full Text] [Related]
13. Current trends in the pharmacotherapy of diabetic retinopathy.
Kumar B; Gupta SK; Saxena R; Srivastava S
J Postgrad Med; 2012; 58(2):132-9. PubMed ID: 22718058
[TBL] [Abstract][Full Text] [Related]
14. Novelties in Diabetic Retinopathy.
Ebneter A; Zinkernagel MS
Endocr Dev; 2016; 31():84-96. PubMed ID: 26824524
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.
Bandello F; Corvi F; La Spina C; Benatti L; Querques L; Capuano V; Naysan J; Chen X; Sarraf D; Parodi MB; Souied E; Freund KB; Querques G
Br J Ophthalmol; 2016 Dec; 100(12):1611-1616. PubMed ID: 26951773
[TBL] [Abstract][Full Text] [Related]
16. A Novel Treatment for Proliferative Diabetic Retinopathy: Anti-Vascular Endothelial Growth Factor Therapy.
Gross JG; Glassman AR
JAMA Ophthalmol; 2016 Jan; 134(1):13-4. PubMed ID: 26583372
[No Abstract] [Full Text] [Related]
17. Treating diabetic retinopathy by inhibiting growth factor pathways.
Frank RN
Curr Opin Investig Drugs; 2009 Apr; 10(4):327-35. PubMed ID: 19337953
[TBL] [Abstract][Full Text] [Related]
18. Niaspan inhibits diabetic retinopathy‑induced vascular inflammation by downregulating the tumor necrosis factor‑α pathway.
Wang Y; Meng X; Yan H
Mol Med Rep; 2017 Mar; 15(3):1263-1271. PubMed ID: 28138697
[TBL] [Abstract][Full Text] [Related]
19. Role of Oxidative Stress in Diabetic Retinopathy and the Beneficial Effects of Flavonoids.
Ola MS; Al-Dosari D; Alhomida AS
Curr Pharm Des; 2018; 24(19):2180-2187. PubMed ID: 29766782
[TBL] [Abstract][Full Text] [Related]
20. The Benefits of Flavonoids in Diabetic Retinopathy.
Matos AL; Bruno DF; Ambrósio AF; Santos PF
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33081260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
